In a recent False Claims Act case involving the mental health drug Geodon, Pfizer reportedly lost its bid to have the case dismissed after unsuccessfully arguing, among other claims, that relators failed the “first-to-file” and “public disclosure” requirements contained within the language of the FCA. Specifically, the FCA precludes whistleblowers […]
The False Claims Act is drafted to address nearly any type of false claim made by an individual or corporation to the federal government. The FCA was originally implemented to address wartime misconduct, but has since grown to include many other instances of fraud. In today’s case, we explore a […]
Late last month, a federal judge reversed a bankruptcy court’s decision to alleviate military aircraft contractor Hawker Beechcraft from liability under a False Claims Act whistleblower lawsuit. The bankruptcy court relied on the fact that military contractor Hawker Beechcraft was recently sold to Textron, Inc. as part of its Chapter […]
The famed manufacturer of the Sikorsky Black Hawk helicopter, Sikorsky Aircraft, has agreed to pay $3.5 million to settle claims it overcharged the U.S. government for services and parts for the powerful utility aircraft. The settlement occurred following a lawsuit filed under the qui tam provisions of the False Claims […]
When a physician, hospital, or pharmaceutical company engages in fraud against the U.S. government, it is not uncommon for the defendant to face additional penalties and sanctions beyond mere repayment of taxpayer dollars. For example, Medicare fraudsters may face incarceration and probation for engaging in this type of crime – […]